News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) To Receive Milestone Payment In Duobody Platform Collaboration With Janssen Biotech Inc. – Financial Guidance Improved


12/6/2013 9:10:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; December 6, 2013 – Genmab A/S (OMX: GEN) announced today it has reached a new milestone in its DuoBody technology platform collaboration with Janssen Biotech, Inc. (“Janssen”), triggering a $4 million milestone. The milestone payment is for pre-clinical progress on the EM1-mAb DuoBody product which targets EGFr and cMet, two validated targets for cancer therapy.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES